About
Autologous, adult stem cell therapy technology
Areas of Focus
Categories
Stem Cell & Cellular TherapyMiddle East
Team (13)
Alla Patlis
Alla Patlis, CPA, MBA
BrainStorm Cell Therapeutics
team_member
Bob Dagher
Bob Dagher, MD
BrainStorm Cell Therapeutics
team_member
Chaim Lebovits
Chaim Lebovits
BrainStorm Cell Therapeutics
team_member
Executive Vice President
Executive Vice President, Chief Operating Officer
BrainStorm Cell Therapeutics
executive
Haro Hartounian
Haro Hartounian, PhD
BrainStorm Cell Therapeutics
team_member
Interim Chief Financial Officer
Interim Chief Financial Officer
BrainStorm Cell Therapeutics
executive
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
493
By Phase
PHASE3: 2PHASE2: 3PHASE1/PHASE2: 1
By Status
COMPLETED: 5NOT_YET_RECRUITING: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT06973629Lead Sponsor
Efficacy and Safety of MSC-NTF (NurOwn) in Participants With Early Symptomatic ALS and Moderate Disease Presentation in ALS (ENDURANCE STUDY)
PHASE3Not yet recruiting
200 participants
Started: Jun 30, 2025 · Completed: May 1, 2029
NCT03799718Lead Sponsor
Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS
PHASE2Completed
23 participants
Started: Mar 13, 2019 · Completed: Mar 30, 2021
NCT03280056Lead Sponsor
Safety and Efficacy of Repeated Administrations of NurOwn® in ALS Patients
PHASE3Completed
196 participants
Started: Aug 28, 2017 · Completed: Sep 29, 2020
NCT02017912Lead Sponsor
Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS
PHASE2Completed
48 participants
Started: May 31, 2014 · Completed: Jul 31, 2016
NCT01777646Lead Sponsor
Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)
PHASE2Completed
14 participants
Started: Dec 31, 2012 · Completed: Sep 30, 2015
Locations (1)
Headquarters
Kiryat Aryeh, Israel
Map
Loading map...